{"id":"dexlan","rwe":[],"tags":[],"phase":"phase_1","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Disease of liver","Fracture of bone","Hypomagnesemia","Osteoporosis"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"active","trials":["NCT02646332","NCT03829150"],"aliases":["Dexlansoprazole MR"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"aiSummary":"Dexlan is a medication used in the treatment of Helicobacter Pylori infection. It is part of a concomitant quadruple therapy regimen that includes Dexlan, amoxicillin, and clarithromycin 500mg, as studied in the clinical trial \"Anti-Helicobacter Pylori Therapy With Dexlansoprazole MR-Based Concomitant Quadruple Therapy- A Prospective Randomized Trial\".","brandName":"Dexlan","companyId":"chang-gung-memorial-hospital","ecosystem":[],"mechanism":{"target":"Sterile alpha and TIR motif-containing protein 1, Cytosolic endo-beta-N-acetylglucosaminidase, Potassium-transporting ATPase","novelty":"","modality":"Small molecule","drugClass":"","explanation":"","oneSentence":"","technicalDetail":""},"commercial":null,"references":[],"_validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T09:13:30.260786+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"companyName":"Chang Gung Memorial Hospital","competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"Dexlan","indications":{"approved":[{"name":"Erosive esophagitis","diseaseId":"erosive-esophagitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Gastroesophageal reflux disease","diseaseId":"gastroesophageal-reflux-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Maintenance of Healing Erosive Esophagitis","diseaseId":"maintenance-of-healing-erosive-esophagitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Peptic ulcer","diseaseId":"peptic-ulcer","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT02646332","phase":"NA","title":"Comparing the Efficacy and Impact on Gastrointestinal Microbiota of Reverse Hybrid Therapy and Concomitant Therapy in Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","isPivotal":false,"enrollment":248,"indication":"Helicobacter Pylori Infection","completionDate":"2020-08-31"},{"nctId":"NCT03829150","phase":"NA","title":"Anti-Helicobacter Pylori Therapy With Dexlansoprazole MR-Based Concomitant Quadruple Therapy- A Prospective Randomized Trial","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","isPivotal":false,"enrollment":202,"indication":"Helicobacter Pylori Infection","completionDate":"2019-04-20"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"","frequency":"","formulation":""},"formularyStatus":[],"apiManufacturers":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Gastroenterology"],"biosimilarFilings":[],"firstApprovalDate":"","companionDiagnostics":[],"firstApprovalCountry":null,"genericManufacturerList":[],"modality":"Small molecule","enrichmentLevel":5,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":1,"lastValidatedAt":"2026-04-20T09:13:30.260786+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}